CME Group Inc.
CME
$267.85
$3.691.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.04% | 11.31% | 10.66% | 4.60% | 17.73% |
| Total Other Revenue | -2.44% | -2.47% | 6.22% | 27.85% | 29.68% |
| Total Revenue | -3.00% | 10.37% | 10.35% | 5.98% | 18.47% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -3.00% | 10.37% | 10.35% | 5.98% | 18.47% |
| SG&A Expenses | 3.09% | 6.85% | 1.95% | 3.89% | 10.37% |
| Depreciation & Amortization | -1.55% | -0.95% | -3.28% | -3.36% | -4.98% |
| Other Operating Expenses | -16.60% | 7.28% | 0.97% | 10.58% | 17.21% |
| Total Operating Expenses | 0.74% | 5.65% | 1.03% | 3.52% | 8.27% |
| Operating Income | -5.04% | 12.86% | 15.46% | 7.51% | 24.87% |
| Income Before Tax | 0.01% | 15.23% | 11.80% | 9.01% | 20.79% |
| Income Tax Expenses | 1.86% | 12.50% | 11.77% | 15.99% | 17.85% |
| Earnings from Continuing Operations | -0.53% | 16.07% | 11.81% | 7.37% | 21.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.53% | 16.07% | 11.81% | 7.37% | 21.67% |
| EBIT | -5.04% | 12.86% | 15.46% | 7.51% | 24.87% |
| EBITDA | -4.77% | 11.79% | 13.93% | 6.54% | 21.97% |
| EPS Basic | -0.60% | 15.96% | 11.71% | 7.27% | 21.54% |
| Normalized Basic EPS | -0.07% | 15.12% | 11.69% | 7.98% | 20.67% |
| EPS Diluted | -0.40% | 16.12% | 11.49% | 7.19% | 21.36% |
| Normalized Diluted EPS | -0.11% | 15.07% | 11.68% | 7.99% | 20.67% |
| Average Basic Shares Outstanding | 0.08% | 0.09% | 0.10% | 0.10% | 0.11% |
| Average Diluted Shares Outstanding | 0.12% | 0.14% | 0.11% | 0.10% | 0.10% |
| Dividend Per Share | 8.70% | 8.70% | 8.70% | 4.55% | 4.55% |
| Payout Ratio | 0.09% | -0.06% | -0.01% | -0.03% | -0.14% |